XHKG
3839
Market cap288mUSD
Jul 10, Last price
9.50HKD
1D
1.06%
1Q
35.91%
Jan 2017
327.93%
IPO
141.73%
Name
Chia Tai Enterprises International Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Chia Tai Enterprises International Limited (CTEI) is a global entity primarily involved in the production and distribution of chlortetracycline (CTC) and its associated derivatives. The company's business activities span Mainland China, the Asia Pacific region, the Americas, Europe, and other international markets, and are organized into two principal divisions: Biochemical and Industrial. The Biochemical segment concentrates on the formulation and commercialization of CTC premix and CTC hydrochloride products. These substances function as crucial feed additives for livestock, designed to foster growth, ward off or alleviate animal ailments, and enhance feed efficiency, marketed under the "Shihao" and "Citifac" brand names. In contrast, the Industrial segment encompasses the sale, rental, and maintenance services for various Caterpillar heavy equipment, including excavators, power generators, bulldozers, and compactors, alongside their corresponding spare parts. This division also undertakes the manufacturing and supply of carburetors and diverse automotive components for vehicle and motorcycle producers. Established in 1987, CTEI's headquarters are located in Central, Hong Kong, and it operates as a subsidiary of Charoen Pokphand Foods Public Company Limited.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||